BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 24634946)

  • 1. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
    Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
    Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?
    Lai CY; Wu CC; Wang J; Yu CC; Cheng SB; Yeh DC; Peng FK
    Hepatogastroenterology; 2014 Oct; 61(135):2068-76. PubMed ID: 25713912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcome in cirrhotic patients with hepatitis C-related hepatocellular carcinoma.
    Hanazaki K; Wakabayashi M; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Kawamura N; Miyazaki T
    Hepatogastroenterology; 2000; 47(31):204-10. PubMed ID: 10690610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.
    Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; Sakamoto T; Tsutsui N; lida T; Matsumoto M; Furukawa K; Haruki K; Hirohara S; Misawa T; Yanaga K
    Hepatogastroenterology; 2013 Oct; 60(127):1681-3. PubMed ID: 24634937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.
    Kaneda K; Kubo S; Tanaka H; Takemura S; Ohba K; Uenishi T; Kodai S; Shinkawa H; Urata Y; Sakae M; Yamamoto T; Suehiro S
    Hepatogastroenterology; 2012 Sep; 59(118):1889-92. PubMed ID: 22819910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.
    Wang WL; Zhu Y; Cheng JW; Li MX; Xia JM; Hao J; Yu L; Lv Y; Wu Z; Wang B
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):444-51. PubMed ID: 24463566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
    Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
    J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of ascites after hepatectomy for patients with hepatocellular carcinoma and hepatitis B virus-associated cirrhosis.
    Chen LP; Li C; Wang C; Wen TF; Yan LN; Li B
    Hepatogastroenterology; 2012; 59(113):292-5. PubMed ID: 21940357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis.
    Chiappa A; Zbar A; Audisio RA; Paties C; Bertani E; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1145-50. PubMed ID: 10370682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?
    Wu CC; Ho WL; Lin MC; Tang JS; Yeh DC; Liu TJ; P'eng FK
    Hepatogastroenterology; 1999; 46(26):635-9. PubMed ID: 10370588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
    Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection in cirrhotic liver for treatment of hepatocellular carcinoma in Egyptian patients. Experience with 140 cases in a single center.
    Abdel Wahab M; Sultan A; el-Ghawalby N; Fathy O; Abu Zeid M; Abu el-Enin A; Abdallah T; Foad A; Kandeel T; el-Shobari M; el-Fiky A; el-Ebidy G; Gadel Hak N; Ezzat F
    Hepatogastroenterology; 2004; 51(56):559-63. PubMed ID: 15086202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis.
    Shi R; Zhang YM; Zhu ZJ; Deng YL; Pan C; Zheng H; Shen ZY
    Hepatogastroenterology; 2014; 61(133):1363-7. PubMed ID: 25436312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients.
    Sheen PC; Lee KT; Chen HY; Chen JS; Ker CG
    Int Surg; 1996; 81(3):280-3. PubMed ID: 9028990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.